Cryofocus Medtech’s Malignant Stenosis Cryoablation System Approved by NMPA for Chinese Market
Shanghai-based cryoablation treatment specialist Cryofocus Medtech (Shanghai) Co., Ltd (HKG: 6922) has announced receiving endorsement...
Roche and JD Healthcare Collaborate on Influenza Prevention with Xofluza (Baloxavir Marboxil)
Swiss giant Roche’s (SWX: ROG, OTCMKTS: RHHBY) China unit has entered into a collaboration agreement...
Suzhou GenAssist’s GEN6050X Receives FDA Clearance for Duchenne Muscular Dystrophy Treatment
China-based Suzhou GenAssist Therapeutic Co., Ltd has announced receiving clearance from the US Food and...
BioRay Biopharmaceutical’s BR111 Receives NMPA Clearance for Clinical Trials in ROR1-Positive Malignancies
Zhejiang-based BioRay Biopharmaceutical has announced receiving clearance from the National Medical Products Administration (NMPA) to...
CStone Pharmaceuticals’ CS5001 Enters Phase Ib Trial for Diffuse Large B-Cell Lymphoma
China-based CStone Pharmaceuticals (HKG: 2616) has announced a Phase Ib clinical filing in Australia for...
Roche’s Gazyva Receives FDA Review Acceptance for Lupus Nephritis Treatment
Swiss pharmaceutical giant Roche (SWX: ROG, OTCMKTS: RHHBY) has announced that the US Food and...
Ascentage Pharma’s Olverembatinib Receives Third BTD in China for Ph+ ALL Treatment
China-based Ascentage Pharma (HKG: 6855) has announced that the Center for Drug Evaluation (CDE) of...
ImmuneOnco’s Timdarpacept (IMM01) and IMM2510 Receive NMPA Approval for Clinical Study in Advanced Malignant Tumors
China-based ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG: 1541) has received approval from the National Medical Products...
CSPC Pharma’s JMT108 Receives NMPA Clinical Approval for Advanced Malignant Tumors
China-based CSPC Pharmaceutical Group Ltd (HKG: 1093) has announced clinical approval from the National Medical...
Sandoz’s Q4 2024 Results Show Strong Biosimilar Growth
Switzerland-headquartered Sandoz (SWX: SDZ) has released its Q4 2024 financial results. The firm’s global revenues...
Peijia Medical Completes First Two Implants of Trilogy THV System in Taiwan
China’s Peijia Medical Ltd (HKG: 9996) announced the completion of the first two implant surgeries...
Huadong Medicine’s V30 Optical Radiofrequency Device Receives NMPA Review Approval
China-based Huadong Medicine Co., Ltd (SHE: 000963) announced that the National Medical Products Administration (NMPA)...
Jiangsu Nhwa Pharmaceutical Invests in NeuroThree to Develop CNS Therapies
China-based Jiangsu Nhwa Pharmaceutical Co., Ltd (SHE: 002262) announced plans to subscribe to Hong Kong-headquartered...
Bayer Posts Steady Q4 Growth, Pharmaceutical Sales Lead the Way
German giant Bayer (ETR: BAYN) has released its Q4 2024 financial results, reporting a 0.7%...
NovoCare Pharmacy Offers Reduced-Cost Wegovy for Cash-Paying Patients
Denmark-based Novo Nordisk A/S (NYSE: NVO) has announced the launch of NovoCare Pharmacy, a direct-to-patient...
Antengene’s Xpovio Receives Marketing Approval in Indonesia
China-based biopharma Antengene Corp., Ltd (HKG: 6996) announced receiving marketing approval in Indonesia for its...
Sino Medical Sciences’ HT Supreme Stent System Gains Vietnamese Marketing Approval
China-based Sino Medical Sciences Technology Inc., (SHA: 688108) announced that it has received marketing approval...
Yifan Pharma Secures Rights to Bayer’s Stivarga and Nexavar in China
China-based Yifan Pharmaceutical Co., Ltd (SHE: 002019) announced a commercialization agreement with Bayer (ETR: BAYN),...
Major Policy Directions in China’s Healthcare Arena: A Comprehensive Breakdown
In a momentous address at the Third Session of the 14th National People’s Congress on...
RongCan Biotech’s mRNA HPV Vaccine Receives FDA Clinical Approval
China-based mRNA specialist RongCan (Shanghai) Biotech Co., Ltd announced that it has received clinical approval...